• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Learning from three centuries of smallpox epidemics in London, UK

Bioengineer by Bioengineer
December 21, 2020
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Olga Krylova and David J.D. Earn

The current COVID-19 pandemic has caused a surge of interest in the study of infectious disease transmission, and how control measures could change the course of the pandemic. New research published on 21st December 2020, in the open access journal PLOS Biology, authored by Olga Krylova of the Canadian Institute for Health Information and David Earn of McMaster University, examines the history of recorded smallpox epidemics in London.

Smallpox, one of the most devastating viral diseases ever to strike humankind, is one of only two infectious diseases that have been successfully eradicated by human efforts. 2020 marks the 40th anniversary of smallpox eradication.

Krylova and Earn studied more than 13,000 weekly smallpox mortality records, from 1664 to 1930, and found that the time between epidemics, the size of the outbreaks, and even the season when the epidemics occurred, changed over the centuries. They also annotated the smallpox time series with major historical events, including the introduction of various control interventions, before and after the discovery of a vaccine in 1796.

The most common pre-vaccination intervention was variolation, which is the practice of carefully controlled intentional infection with a small dose of live virus, leading to immunity with lower risk of death than from natural infection. Variolation has made news recently because it has been suggested that “variolation” with COVID-19 might be occurring as a beneficial side-effect of the use of masks.

The researchers digitized the weekly records published in the London Bills of Mortality and the Registrar General’s Weekly Returns. These data provide a rare and valuable source for the study of ecology and evolution of infectious diseases.

“Our goal was to describe and make publicly available the weekly time series of smallpox mortality in London, and to identify historical events that might have influenced smallpox dynamics over the centuries,” says author David Earn, a professor of mathematics who specializes in modelling of infectious disease transmission.

During the time period covered by the data, smallpox changed from a terrifying and unavoidable danger to an easily preventable infection. Introduction of better control measures, especially vaccination, naturally led to decreased smallpox mortality and eventually eradication. Krylova and Earn present the first statistical analyses of these extraordinary, weekly historical records.

###

Peer reviewed; Observational study; People

In your coverage please use these URLs to provide access to the freely available articles in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000506

Citation: Krylova O, Earn DJD (2020) Patterns of smallpox mortality in London, England, over three centuries. PLoS Biol 18(12): e3000506. https://doi.org/10.1371/journal.pbio.3000506

Funding: Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca). NSERC Discovery Grant to DE. NSERC Postgraduate Scholarship to OK. J. S. McDonnell Foundation (JSMF, http://jsmf.org) Research Grant to DE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Media Contact
David Earn
[email protected]

Related Journal Article

http://dx.doi.org/10.1371/journal.pbio.3000506

Tags: BiologyEnvironmental HealthEpidemiologyImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthPublic HealthVaccinesVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    44 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dental Stem Cells Differentiate on Biodentine Nanofibers

CSF ctDNA: New Biomarker for NSCLC Brain Mets

2-Hydroxyglutarate Drives Brown Fat Whitening via Nuclear Softening

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.